Morgan Stanley analyst Craig Hettenbach lowered the firm’s price target on HCA Healthcare (HCA) to $355 from $406 and keeps an Equal Weight rating on the shares. Diversified Managed Care “woefully underperformed” in 2024 and while uncertainty is pressuring sentiment, the firm sees “opportunities in a friendlier policy backdrop,” the analyst tells investors in a 2025 outlook note on the healthcare services group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare assumed with a Neutral at JPMorgan
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Block, Five Below downgraded: Wall Street’s top analyst calls
- HCA Healthcare downgraded to Underweight from Equal Weight at Wells Fargo
- Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz